Premium
FIL‐PTCL13: PHASE IB/II STUDY OF ROMIDEPSIN/CHOEP FOLLOWED BY HIGH‐DOSE CHEMOTHERAPY AND TRANSPLANTATION IN UNTREATED PERIPHERAL T‐CELL LYMPHOMAS.
Author(s) -
Chiappella A.,
Carniti C.,
Ceccarelli M.,
Cabras M.G.,
Re A.,
Salvi F.,
Santoro A.,
Stefoni V.,
Pileri S.,
Ciccone G.,
Corradini P.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2440_10
Subject(s) - romidepsin , medicine , anaplastic large cell lymphoma , oncology , clinical endpoint , transplantation , chemotherapy , autologous stem cell transplantation , lymphoma , progressive disease , peripheral t cell lymphoma , gastroenterology , surgery , immunology , t cell , biology , clinical trial , biochemistry , histone deacetylase , gene , histone , immune system
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom